Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Wullich

Showing results (201-210 of 251) with videos related to

Pageof 26
Sort By:
Journal of Clinical Medicine|April 8, 2020
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical CystectomyDanijel Sikic, Markus Eckstein, Ralph M Wirtz, et al.
Urologia Internationalis|June 22, 2026
Pilot Survey about the perspective on Generation Z among European leaders in Urology: Challenges in educating Generation ZJulian Endres, Yana Terziyska, Bernd Wullich, et al.
Clinical Genitourinary Cancer|March 18, 2020
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell CarcinomaUlrich Sommer, Markus Eckstein, Johannes Ammann, et al.
BMC Cancer|September 14, 2018
Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trialKristin Schink, Hans J Herrmann, Raphaela Schwappacher, et al.
Biomed Research International|May 31, 2014
Association of tissue mRNA and serum antigen levels of members of the urokinase-type plasminogen activator system with clinical and prognostic parameters in prostate cancerOmar Al-Janabi, Helge Taubert, Andrea Lohse-Fischer, et al.
Cancers|June 2, 2021
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer PatientsVeronika Weyerer, Pamela L Strissel, Reiner Strick, et al.
Histopathology|July 27, 2019
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinomaVeronika Weyerer, Rebecca Weisser, Evgeny A Moskalev, et al.
Oncotarget|March 15, 2018
Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patientsVerena Lieb, Katrin Weigelt, Lena Scheinost, et al.
Human Pathology|June 10, 2018
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtypeUlrike Zinnall, Veronika Weyerer, Eva Compérat, et al.
Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
Pageof 26

Showing results (201-210 of 251) with videos related to

Sort By:
Pageof 26
Journal of Clinical Medicine|April 8, 2020
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical CystectomyDanijel Sikic, Markus Eckstein, Ralph M Wirtz, et al.
Urologia Internationalis|June 22, 2026
Pilot Survey about the perspective on Generation Z among European leaders in Urology: Challenges in educating Generation ZJulian Endres, Yana Terziyska, Bernd Wullich, et al.
Clinical Genitourinary Cancer|March 18, 2020
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell CarcinomaUlrich Sommer, Markus Eckstein, Johannes Ammann, et al.
BMC Cancer|September 14, 2018
Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trialKristin Schink, Hans J Herrmann, Raphaela Schwappacher, et al.
Biomed Research International|May 31, 2014
Association of tissue mRNA and serum antigen levels of members of the urokinase-type plasminogen activator system with clinical and prognostic parameters in prostate cancerOmar Al-Janabi, Helge Taubert, Andrea Lohse-Fischer, et al.
Cancers|June 2, 2021
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer PatientsVeronika Weyerer, Pamela L Strissel, Reiner Strick, et al.
Histopathology|July 27, 2019
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinomaVeronika Weyerer, Rebecca Weisser, Evgeny A Moskalev, et al.
Oncotarget|March 15, 2018
Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patientsVerena Lieb, Katrin Weigelt, Lena Scheinost, et al.
Human Pathology|June 10, 2018
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtypeUlrike Zinnall, Veronika Weyerer, Eva Compérat, et al.
Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
Pageof 26